The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Byam Rebecca since 2021.
This trader's CIK number is 1866256.
At the time of last reporting, Byam Rebecca was the Chief Financial Officer of Hcw Biologics Inc.. (stock ticker symbol HCWB).
Also see all insider trading activities at Hcw Biologics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | HCWB | 8,462 | $220,012 | 0 | $0 | 0 | $0 |
| 2023 | HCWB | 212,244 | $377,869 | 0 | $0 | 47,249 | $6,614 |
| 2022 | HCWB | 113,652 | $283,104 | 0 | $0 | 0 | $0 |
| 2021 | HCWB | 35,000 | $243,980 | 0 | $0 | 27,000 | $3,780 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-08 | HCWB | Buy | 8,462 | 26.00 | 220,012 |
| 2023-10-19 | HCWB | Option Ex | 47,249 | .14 | 6,614 |
| 2023-09-13 | HCWB | Buy | 5,000 | 2.10 | 10,490 |
| 2023-09-11 | HCWB | Buy | 5,000 | 2.06 | 10,275 |
| 2023-09-12 | HCWB | Buy | 5,000 | 2.09 | 10,440 |
| 2023-09-08 | HCWB | Buy | 5,000 | 2.02 | 10,109 |
| 2023-09-07 | HCWB | Buy | 5,000 | 1.95 | 9,740 |
| 2023-09-06 | HCWB | Buy | 5,000 | 1.95 | 9,750 |
| 2023-06-09 | HCWB | Buy | 20,000 | 2.06 | 41,280 |
| 2023-06-08 | HCWB | Buy | 4,696 | 2.21 | 10,387 |
| 2023-06-07 | HCWB | Buy | 20,000 | 2.03 | 40,640 |
| 2023-06-05 | HCWB | Buy | 20,000 | 1.67 | 33,340 |
| 2023-06-06 | HCWB | Buy | 19,062 | 1.82 | 34,788 |
| 2023-05-25 | HCWB | Buy | 20,000 | 1.62 | 32,340 |
| 2023-05-26 | HCWB | Buy | 20,000 | 1.66 | 33,200 |
| 2023-05-24 | HCWB | Buy | 20,000 | 1.61 | 32,160 |
| 2023-05-22 | HCWB | Buy | 33,450 | 1.53 | 51,044 |
| 2023-05-23 | HCWB | Buy | 5,036 | 1.57 | 7,886 |
| 2022-09-12 | HCWB | Buy | 15,000 | 2.65 | 39,765 |
| 2022-09-13 | HCWB | Buy | 15,000 | 2.58 | 38,655 |
| 2022-08-31 | HCWB | Buy | 10,000 | 2.56 | 25,570 |
| 2022-08-30 | HCWB | Buy | 7,200 | 2.55 | 18,338 |
| 2022-06-13 | HCWB | Buy | 7,596 | 2.08 | 15,814 |
| 2022-06-14 | HCWB | Buy | 58,856 | 2.46 | 144,962 |
| 2021-11-23 | HCWB | Option Ex | 27,000 | .14 | 3,780 |
| 2021-08-19 | HCWB | Buy | 10,000 | 4.40 | 43,980 |
| 2021-07-22 | HCWB | Buy | 25,000 | 8.00 | 200,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Byam Rebecca (Chief Financial Officer of Hcw Biologics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.